Back | Next |
home / stock / apls / apls message board
Subject | By | Source | When |
---|---|---|---|
Thoughts on where this is headed? | IPO$ | investorshub | 04/13/2023 12:28:59 PM |
Anyone hear anything lately? Want to see this one go | ClayTrader | investorshub | 04/13/2023 2:05:13 AM |
$APLS The now | conix | investorshub | 04/13/2023 12:13:02 AM |
Price now up | ComptonBrosInc | investorshub | 04/12/2023 6:07:56 PM |
short squeeze article | IPO$ | investorshub | 04/12/2023 3:26:11 AM |
Time for a bounce? | conix | investorshub | 04/12/2023 3:18:49 AM |
When is this gonna take off? | IPO$ | investorshub | 04/11/2023 8:57:30 PM |
we got news | IPO$ | investorshub | 04/11/2023 6:09:49 PM |
$APLS are we finally gonna see some action | ComptonBrosInc | investorshub | 04/10/2023 10:43:03 AM |
The now up | IPO$ | investorshub | 04/10/2023 10:34:20 AM |
just the news we needed | wantprofits | investorshub | 04/09/2023 11:34:13 PM |
$APLS The now last trade up | IPO$ | investorshub | 04/09/2023 9:44:24 PM |
$APLS and the shorts continue | ClayTrader | investorshub | 04/09/2023 7:42:12 PM |
we got news | ClayTrader | investorshub | 04/09/2023 10:00:42 AM |
Have a look at this | conix | investorshub | 04/08/2023 10:11:29 AM |
The trading last trade up | wantprofits | investorshub | 04/08/2023 4:19:22 AM |
what do you make of this data? | IPO$ | investorshub | 04/08/2023 2:25:25 AM |
$APLS MomentumIts trading | IPO$ | investorshub | 04/05/2023 2:43:24 PM |
Lets go go go go... Up up and away we go. | IPO$ | investorshub | 04/04/2023 2:18:47 PM |
$APLS Price now last up | IPO$ | investorshub | 04/04/2023 10:02:38 AM |
News, Short Squeeze, Breakout and More Instantly...
Apellis Pharmaceuticals Inc. Company Name:
APLS Stock Symbol:
NASDAQ Market:
Apellis Pharmaceuticals Inc. Website:
WALTHAM, Mass., July 18, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals , Inc. (Nasdaq: APLS) today announced that the company will host a conference call and webcast to discuss its second quarter 2024 financial results on Thursday, August 1, 2024, at 8:30 a.m. ET. To access ...
Late-breaking presentation shows SYFOVRE® (pegcetacoplan injection) demonstrated visual function benefit on prespecified endpoint in GALE long-term extension study WALTHAM, Mass., July 09, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that six ...
WALTHAM, Mass., June 28, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a negative opinion on the marketing authorization application (MAA) of i...